Source:http://linkedlifedata.com/resource/pubmed/id/16293184
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
10
|
| pubmed:dateCreated |
2005-11-18
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Nov
|
| pubmed:issn |
0303-6987
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
32
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
700-3
|
| pubmed:meshHeading |
pubmed-meshheading:16293184-Cell Cycle Proteins,
pubmed-meshheading:16293184-Cyclin-Dependent Kinase Inhibitor p27,
pubmed-meshheading:16293184-Humans,
pubmed-meshheading:16293184-Melanoma,
pubmed-meshheading:16293184-Prognosis,
pubmed-meshheading:16293184-Risk Assessment,
pubmed-meshheading:16293184-Skin Neoplasms,
pubmed-meshheading:16293184-Tumor Markers, Biological
|
| pubmed:year |
2005
|
| pubmed:articleTitle |
Markers of high-risk cutaneous melanoma: is there a winning combination for individualized prognosis?
|
| pubmed:publicationType |
Letter,
Comment
|